Hori Seiji
Department of Pharmacology, Jikei University School of Medicine, Tokyo, Japan.
Yakugaku Zasshi. 2011;131(10):1423-8. doi: 10.1248/yakushi.131.1423.
Many antibiotics have been developed and used for the treatment of infectious diseases. Although they have been known to have various adverse effects, most of the mechanisms remain still unknown. New quinolones are well known to induce convulsions and their convulsant activity enhanced by concurrent administration of anti-inflammatory drugs. Each new quinolone has an individual convulsant activity with individual drug-interaction with anti-inflammatory drugs. And enoxacin, lomefloxacin and gatifloxacin have been reported to decrease blood glucose levels in a dose-depend- ent manner, but ciprofloxacin and levofloxacin had no effect on the levels. It should be important to know the safety profile of antimicrobial agents before doctors administer these agents to the patients with infectious diseases.
许多抗生素已被研发并用于治疗传染病。尽管已知它们有各种不良反应,但其大多数机制仍不明。众所周知,新型喹诺酮类药物会诱发惊厥,且同时服用抗炎药会增强其惊厥活性。每种新型喹诺酮类药物都有各自的惊厥活性以及与抗炎药的个体药物相互作用。据报道,依诺沙星、洛美沙星和加替沙星可使血糖水平呈剂量依赖性降低,但环丙沙星和左氧氟沙星对血糖水平无影响。在医生给传染病患者使用这些抗菌药物之前,了解其安全性概况应很重要。